Citadel Advisors
MEDX icon

Citadel Advisors’s Horizon Kinetics Medical ETF MEDX Stock Holding History

Citadel Advisors’s Portfolio MEDX Stock Details MEDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,635
Closed -$488K – 14051
2025
Q1 		$488K Buy
17,635
+4,459
+34% +$123K ﹤0.01% 8527
2024
Q4 		$344K Buy
+13,176
New +$379K ﹤0.01% 9373

Other funds holding MEDX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors's MEDX Position: Q2 2025 in Review

Citadel Advisors sold out of Horizon Kinetics Medical ETF (MEDX) in Q2 2025, closing a stake of 17,635 shares — an estimated $488K sold.

Citadel Advisors first reported a position in MEDX in Q4 2024 and held it in 2 quarters. The position peaked at $488K in Q1 2025. 5 funds tracked by Wall St. Rank hold MEDX as of Q2 2025.

  • Citadel Advisors reported no remaining Horizon Kinetics Medical ETF position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 17,635 Horizon Kinetics Medical ETF shares in Q2 2025, an estimated $488K.
  • Citadel Advisors first reported a position in Horizon Kinetics Medical ETF in Q4 2024 and held it in 2 quarters.
  • Citadel Advisors's Horizon Kinetics Medical ETF position peaked at $488K in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Horizon Kinetics Medical ETF as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.